Insulin-like Growth Factor-1 in Coronary Heart Disease

朱志军,黄元伟,朱建华,陈君柱

DOI: https://doi.org/10.3969/j.issn.1007-5410.2003.06.008

2003-01-01

Abstract:Objective To explore the possible mechanism of insulin-like growth factor 1 (IGF1) in coronary heart disease(CAD). Methods The peripheral vein and coronary sinus serum levels of IGF1 in patients with CAD confirmed by selective coronary angiography and the peripheral vein serum levels of IGF1 in control were measured. The relationship between the coronary vein sinus serum levels of IGF1 and the number of narrow artery in patients was analyzed. Results The peripheral vein serum levels of IGF1 in patients were lower than that in control group(respectively 25.39±13.32 μg/l and 48.02±33.43 μg/l,P0.05). The coronary vein sinus serum levels of IGF1 were higher than that of peripheral vein serum levels in patients(44.17±15.58 μg/l vs 25.39±13.32 μg/l,P0.05). The coronary vein sinus serum levels of IGF1 in patients were similar to that of the peripheral veins in control group. The difference became much more significant with the much narrow artery numbers than one narrow artery of the patients levels of IGF1.There was a positive correlation between the coronary vein sinus serum levels of IGF1 and the number of diseased coronary artery in patients(r=0.537, P0.05). Conclusion IGF1 may take part in the pathophysiological process of coronary heart disease.